Viatris Inc 2022-05-18 Health serious FDA
Health · FDA · Recall #FDA-D-0854-2022
Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only,… Recall
Issued May 18, 2022 · Viatris Inc
In May 2022, Viatris Inc recalled the Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Dissolution Specifications: low out of specification results for dissolution.
What you should do
- 1 Stop using Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Viatris Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Viatris Inc
- Category
- Health
- Recall date
- May 18, 2022
- Units affected
- Not reported
- Sold at
- Product was distributed nationwide in the USA
- Recall number
- FDA-D-0854-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Viatris Inc has 9 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.